Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INCB099280 and Axitinib in Advanced Solid Tumors
NCT05949632Phase 2Terminated
- Sponsor
- Incyte
- Start
- Apr 2024
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of incb099280 in solid tumor (advanced stage), Clear-cell gynecological cancer, Gynecologic epithelial cancer, sponsored by Incyte. Started Apr 2024; status: terminated.
02
Drugs
incb099280
03
Conditions
solid tumor (advanced stage)Clear-cell gynecological cancerGynecologic epithelial cancer
Beyond the preview
Go deeper on NCT05949632.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05949632.